Newsroom-Katalog

Zeit	Boehringer Ingelheim: Meldungen vom 28.09.2009
08:09	Boehringer Ingelheim's Diabetes Pipeline Continues to Advance as the Company Announces Conclusion of Robust Phase III Pivotal Trials Programme for linagliptin